Trials / Withdrawn
WithdrawnNCT01416701
Vitamin D and Chronic Obstructive Lung Disease
Vitamin D and COPD. A Randomised, Double-blind, Placebo-controlled Trial of the Effect of Vitamin D on Withdrawal From Pulmonary Rehabilitation and Exercise Endurance
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Jorgen Vestbo · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the effect of vitamin D intervention in patients with chronic obstructive pulmonary disease (COPD) undergoing rehabilitation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitamin D (D3, cholecalciferol) | Week 0-4: 152 mcg/daily (4 tablets) Week 5-52: 76 mcg/daily (2 tablets) |
| DIETARY_SUPPLEMENT | Placebo (cellulose) | Week 0-4: 4 tablets daily Week 4-52: 2 tablets daily |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-10-01
- Completion
- 2013-12-01
- First posted
- 2011-08-15
- Last updated
- 2013-04-09
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01416701. Inclusion in this directory is not an endorsement.